21484374

Source:http://linkedlifedata.com/resource/pubmed/id/21484374

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0027651, umls-concept:C0031809, umls-concept:C0450442, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C1709630, umls-concept:C1710493, umls-concept:C2911692
pubmed:issue	8
pubmed:dateCreated	2011-6-30
pubmed:abstractText	We determined whether [(18)F]fluorothymidine (FLT) positron emission tomography (PET) can detect early effects on tumor proliferation of JAC106, a new anti-tubulin agent.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101140988
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Dideoxynucleosides, http://linkedlifedata.com/resource/pubmed/chemical/Thymidine Kinase, http://linkedlifedata.com/resource/pubmed/chemical/Tubulin, http://linkedlifedata.com/resource/pubmed/chemical/Tubulin Modulators, http://linkedlifedata.com/resource/pubmed/chemical/alovudine, http://linkedlifedata.com/resource/pubmed/chemical/thymidine kinase 1
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1619-7089
pubmed:author	pubmed-author:ChungJin HwaJH, pubmed-author:KangHye YoungHY, pubmed-author:KangJong SoonJS, pubmed-author:KimHwan MookHM, pubmed-author:KimMyung-HwaMH, pubmed-author:KimSeog YoungSY, pubmed-author:KimSung-BaeSB, pubmed-author:LeeSeung JinSJ, pubmed-author:MoonDae HyukDH, pubmed-author:OhSeung JunSJ, pubmed-author:ParkSong-KyuSK, pubmed-author:RyuJin-SookJS
pubmed:issnType	Electronic
pubmed:volume	38
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1436-48
pubmed:meshHeading	pubmed-meshheading:21484374-Animals, pubmed-meshheading:21484374-Antineoplastic Agents, pubmed-meshheading:21484374-Biological Transport, pubmed-meshheading:21484374-Cell Line, Tumor, pubmed-meshheading:21484374-Cell Proliferation, pubmed-meshheading:21484374-Dideoxynucleosides, pubmed-meshheading:21484374-Humans, pubmed-meshheading:21484374-Male, pubmed-meshheading:21484374-Mice, pubmed-meshheading:21484374-Mitosis, pubmed-meshheading:21484374-Neoplasms, pubmed-meshheading:21484374-Positron-Emission Tomography, pubmed-meshheading:21484374-Protein Multimerization, pubmed-meshheading:21484374-Protein Structure, Quaternary, pubmed-meshheading:21484374-Thymidine Kinase, pubmed-meshheading:21484374-Time Factors, pubmed-meshheading:21484374-Tubulin, pubmed-meshheading:21484374-Tubulin Modulators, pubmed-meshheading:21484374-Tumor Burden, pubmed-meshheading:21484374-Xenograft Model Antitumor Assays
pubmed:year	2011
pubmed:articleTitle	Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹?F]fluorothymidine in preclinical tumor models.
pubmed:affiliation	Institute for Innovative Cancer Research, University of Ulsan College of Medicine, Asan Medical Center, Pungnap 2-dong, Songpa-gu, Seoul 138-736, Korea.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't